	Native T(1) mapping of the terminal ileum in Crohn's disease: an exploratory study. Acta Radiol Grassi G, Chabert GL, Balestrieri A, Porcu M, Argiolas GM, Cherchi MV, Saba L. PMID: 42159273 [PubMed - as supplied by publisher]
	Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis. J Crohns Colitis Bernstein CN, Kaplan GG, Nugent Z, Ahuja V, Ananthakrishnan AN, Banerjee R, Burisch J, Chen Y, Epstein D, Forbes AJ, Gonczi L, Gu Y, Gunawan J, Hang DV, Kaibullayeva J, Kopylov U, Kotze PG, Iade B, Lakatos PL, Limsrivilai J, Liang J, Mak JWY, Ng S, Severs M, Shen J, Sood A, Yamamoto-Furusho JK, Yuan S, Wewer MD, Wu K, Windsor JW, Gearry RB, Globalization Cluster of the International Organization for the Study of IBD. PMID: 42159039 [PubMed - indexed for MEDLINE]
	Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus. J Crohns Colitis Wils P, Jairath V, Sands BE, Dignass A, Magro F, Rubin DT, Dotan I, Reinisch W, Dulai P, Gearry R, Ma C, Long M, Armuzzi A, Kobayashi T, Turner D, Vieujean S, Verstockt B, Hart A, Danese S, Peyrin-Biroulet L. PMID: 42159038 [PubMed - indexed for MEDLINE]
	Exosomes in Inflammatory Bowel Disease: Mechanisms, Diagnostic Potential, and Engineering Strategies for Precision Therapy. Int J Med Sci Zhao ZK, Ma JL, Lu F, Wang SJ. PMID: 42158829 [PubMed - indexed for MEDLINE]
	NPHR, FPR, and PLT as predictors of ulcerative colitis severity: a single-center retrospective study in China. Front Med (Lausanne) Yang S, Liang D, Qin Y, Dai F, Zhou G, Zhu F. PMID: 42158139 [PubMed]
	The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study. Pharmacoepidemiol Drug Saf Harrison M, Blitz S, Law M, Tadrous M, Gomes T, Clement F, Rosenfeld G, Anis A, Bansback N. PMID: 42157439 [PubMed - indexed for MEDLINE]
	Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study. BMC Gastroenterol El Ouali S, Baker ME, Lu C, Medellin A, Bruining DH, Fletcher JG, Inoue A, Regueiro M, Ottichilo RK, Schoenoff S, Rosentreter R, Bena J, Qazi T, Holubar SD, Gauriloff S, Gandhi NS, Falloon K, Sleiman J, Cohen BL, Goren I, Balci N, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. PMID: 42157112 [PubMed - as supplied by publisher]
	Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study". Intest Res Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S. PMID: 42156082 [PubMed - as supplied by publisher]
	Comments on "Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan". Intest Res Xu C, Li H. PMID: 42156081 [PubMed - as supplied by publisher]
	Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis. Pharmacoepidemiol Drug Saf Rutanen J, Heino P, Sarnola K, Kurko T. PMID: 42156017 [PubMed - indexed for MEDLINE]
	Acute severe ulcerative colitis: efficacy and safety of JAK inhibitors. Expert Opin Pharmacother Bruno A, Bencardino S, D'Amico F, Peyrin-Biroulet L, Danese S. PMID: 42155464 [PubMed - as supplied by publisher]
	Clinicopathological features and cancer-specific survival in young patients with ulcerative colitis-associated colorectal neoplasia: a nationwide cohort study in Japan. Inflamm Bowel Dis Shinagawa T, Komatsu K, Uchino M, Ikeuchi H, Shigeta K, Oka S, Higashi D, Ogawa S, Watanabe K, Shibutani M, Okita Y, Wakai T, Mizuuchi Y, Okamoto K, Yamada K, Sato Y, Ogino T, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Yamamoto T, Yamamoto S, Koyama F, Hiro J, Komori K, Shida D, Arakaki J, Fujita F, Matsuyama T, Ueno H, Ochiai H, Maemoto A, Nezu R, Sasaki S, Sunami E, Noguchi T, Sugihara K, Ajioka Y, Ishihara S, Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by Japanese Society for Cancer of the Colon and Rectum. PMID: 42154979 [PubMed - as supplied by publisher]
	Patient acceptability of partial enteral nutrition as a concomitant therapy to Adalimumab in adults with active Crohn's disease - BIOPIC trial. Ann Nutr Metab Fandinga C, Clowe J, White B, Campbell I, Seenan JP, Brownson E, Milling S, Koutsos A, Ho GT, Mowat C, Robertson E, Gaya DR, Kefayat A, Din S, MacDonald J, Gerasimidis K. PMID: 42154650 [PubMed - as supplied by publisher]
	Intestinal Epithelial Cell Ferroptosis in Ulcerative Colitis: Pathogenesis, Signaling Networks, and Therapeutic Implications. Curr Med Sci Zhao ZQ, Yu ZX, Liu ZQ, Yu T, Fan H. PMID: 42154151 [PubMed - as supplied by publisher]
	A comparative analysis of corticosteroids and exclusive enteral nutrition induction therapy in children with small bowel Crohn's disease: results of two prospective cohorts. Eur J Pediatr Klomberg RCW, Griffiths AM, Aloi M, Kiparissi F, Lawrence S, Otley AR, Critch J, van der Feen C, Rodrigues A, Mack DR, Huynh HQ, Church PC, Rizopoulos D, Croft NM, de Ridder L, Walters TD, European Paediatric IBD Network for Safety, Efficicacy of Treatment and Quality Improvement of Care (PIBD-SETQuality), Canadian Children IBD Network (CIDsCaNN). PMID: 42154069 [PubMed - indexed for MEDLINE]
	Revolutionizing Crohn's disease detection: integrating AI with intestinal ultrasound for superior diagnosis. Ther Adv Gastroenterol Huang R, Zhong M, Hong C, Liu Z, Chen K, Li X, Lu Q, Liu Q, Li Z, Jiang C, Jian G, Su P. PMID: 42153214 [PubMed]
	Short-term efficacy and safety of infliximab biosimilar (HS626) in inducing remission of inflammatory bowel disease: A real-world single-center study. Medicine (Baltimore) Huang YS, Lai DP, Nong H, Zhang T, Chen ZY, Zeng WB, Huang XP, Lin YY. PMID: 42152434 [PubMed - indexed for MEDLINE]
	Dynamic changes in serum gelsolin combined with clinical parameters to construct a predictive model for mucosal healing in inflammatory bowel disease: A prospective cohort study. Medicine (Baltimore) Zhang Y, Zhao Q, Miao J, Tu J, Wang P, Li A, Li J. PMID: 42152368 [PubMed - indexed for MEDLINE]
	Mendelian randomization analyses explore the relationship between inflammatory bowel disease and genitourinary diseases. Medicine (Baltimore) Cao H, Shi C, Dai X, Yuan B, Yang G, Wang S. PMID: 42152343 [PubMed - indexed for MEDLINE]
	HOCl-Mediated Bromothymol Blue Bleaching and Carbon Dot Fluorescence Recovery for Fecal Myeloperoxidase Quantification in Ulcerative Colitis. J Fluoresc Alasiri G, Alaseem AM, El-Wekil MM, Ali R, Ali ABH. PMID: 42151651 [PubMed - as supplied by publisher]

Articles 1 - 20 / 57655

Page 1 of 2883



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy